Clinical trial tag: Recurrence

 

A woman smiles at a nurse while having chemotherapy
Closed trial

RAMP 201: A study of Defactinib and Avutometinib in recurrent low grade serous ovarian cancer

In this study, researchers want to find out how safe and effective it is to use two new drugs, alone or in combination, to treat recurrent, low grade serous ovarian cancer (LGSOC).The drugs used in this trial are both a type of drug called a kinase inhibitor. Kinase inhibitors block cancer cell growth.The drugs involved in this trial are:Defactinib…

Equipment used in chemotherapy with a woman looking at her phone during her treatment in the background
Closed trial

LEAP 005: A trial of lenvatinib and pembrolizumab in advanced solid cancers

The purpose of this study is to determine if a combination of two different anti-cancer drugs are safe and effective in treating different types of solid tumours, including ovarian cancer. It's for women with ovarian cancer whose cancer has continued to spread and grow despite standard chemotherapy treatments. The drugs involved in this trial are k…

An ovarian cancer researching looking into a microscope
Closed trial

Centurion: a trial looking at rucaparib with immunotherapy in relapsed ovarian cancer

The purpose of this trial is to find out how safe and effective it is to have either one or two immunotherapy drugs alongside the parp inhibitor Rucaparib. Researchers want to find out if using the different combination of drugs will prolong the time it takes for your cancer to come back compared with being treated with Rucaparib on its own. The…

A nurse talking and smiling with a woman during chemotherapy
Closed trial

ATARI: A trial looking at the drugs ceralasertib and olaparib for rarer gynaecological cancers

Recruitment to this trial is currently paused. The researchers in this trial are looking to find how out how well the drug ceralasertib (on its own) and the combination of the drugs ceralasertib and olaparib work in rarer types of gynaecological cancers. The drugs used in this clinical trial are: Ceralasertib is a drug called an ATR inh…

Close up of a woman looking at Target Ovarian Cancer's website on her phone during chemotherapy
Closed trial

CEBOC: A study into the safety of cediranib in the prevention of bowel perforation

The main purpose of conducting the trial is to: determine the safety of combining cediranib, a VEGF inhibitor, with paclitaxel a weekly chemotherapy regime find out how well the treatment works in terms of shrinking the cancer and preventing bowel obstruction. If the cancer responds to this treatment then after the course of paclitaxel…

Close up of two people with painted nails holding hands
Closed trial

ICON9: A study of olaparib and cediranib in recurrent ovarian cancer

This trial looks to answer the question as to whether two different types of anti-cancer drugs, given as maintenance treatment are: safe effective well-tolerated Maintenance treatment is a type of targeted therapy that is given to try to prevent or delay the cancer's return after it has responded to chemotherapy. …